# EDGAR Filing Document

**Accession Number:** 0001811115
**File Stem:** 0000950170-23-007329
**Filing Date:** 2023-3
**Character Count:** 2746
**Document Hash:** 4180efade52135be015ac49c45698823
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000950170-23-007329.hdr.sgml**: 20230310

**ACCESSION NUMBER**: 0000950170-23-007329

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230310

**FILED AS OF DATE**: 20230310

**DATE AS OF CHANGE**: 20230310

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Renalytix plc
- **CENTRAL INDEX KEY:** 0001811115
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MEDICAL LABORATORIES [8071]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39387
- **FILM NUMBER:** 23724408

**BUSINESS ADDRESS:**
- **STREET 1:** FINSGATE
- **STREET 2:** 5-7 CRANWOOD STREET
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** EC1V 9EE
- **BUSINESS PHONE:** 44 29 2071 0570

**MAIL ADDRESS:**
- **STREET 1:** FINSGATE
- **STREET 2:** 5-7 CRANWOOD STREET
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** EC1V 9EE

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Renalytix AI plc
- **DATE OF NAME CHANGE:** 20200430

------

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

------

**FORM 6-K** 

------

**REPORT OF FOREIGN PRIVATE ISSUER** 

**PURSUANT TO RULE 13a-16 OR 15d-16** 

**UNDER THE SECURITIES EXCHANGE ACT OF 1934** 

**Date of report: March 10, 2023** 

**Commission File Number: 001-39387** 

------

**Renalytix plc** 

**(Translation of registrant's name into English)** 

------

**Finsgate** 

**5-7 Cranwood Street** 

**London EC1V 9EE** 

**United Kingdom** 

**(Address of principal executive office)** 

------

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

☒ Form 20-F ☐ Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

------

**INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K** 

**Announcement**

Renalytix plc (the "Company") is aware of media reports indicating the closure of Silicon Valley Bank ("SVB"). The Company does not hold any cash at SVB and it does not have any banking relationship with SVB.

------

**SIGNATURES** 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
| RENALYTIX PLC | RENALYTIX PLC |
| By: | /s/ James McCullough |
|  | James McCullough |
|  | Chief Executive Officer |

---

Date: March 10, 2023

------